After a treatment period, dogs which received the probiotic had improved short-chain fatty acid content, microbiome composition, and functional metagenome.
Gateway Health Sciences’ Dichrostachys glomerata extract was associated with greater weight loss, reduced food cravings, and improved mood compared to placebo.
Two patented botanical extracts were associated with significant increases in GLP-1 blood levels and significant weight loss in 90 overweight/obese subjects.
Private label brand PharmaLinea’s vitamin and nucleotide complex appeared to offer greater benefit than placebo in a population undergoing physical therapy.
Forty peri- and early post-menopausal subjects who took blackcurrant powder for 6 months had improvements in whole-body bone density and related biomarkers.
The review addresses clinical studies on the botanical formulas’ effects on gut motility, microbioal balance, inflammation, and overall digestive well-being.
The peptides were evaluated in two separate studies on visible signs of skin beauty and bioavailability, with results to be presented at Vitafoods Asia.
The bitter hops extract, which is associated with GLP-1 activation, has now been subject to three studies examining its potential in appetite reduction.
The blend of rosemary, olive leaves, lemon verbena, and Japanese pagoda tree was linked to improved physiological measures of scalp health after 12 weeks.
During smoking cessation, supplementing with IFF’s Neuravena was associated with better self-reported mood, sleep, and overall well-being over eight weeks.